These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31820708)

  • 1. Effectiveness and Safety of Amphotericin B Deoxycholate, Amphotericin B Colloidal Dispersion, and Liposomal Amphotericin B as Third-Line Treatments for Cutaneous and Mucocutaneous Leishmaniasis: A Retrospective Study.
    Rodríguez Galvis MC; Pérez Franco JE; Casas Vargas MY; Ordoñez Rubiano MF
    Am J Trop Med Hyg; 2020 Feb; 102(2):274-279. PubMed ID: 31820708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study.
    Santos CR; Tuon FF; Cieslinski J; de Souza RM; Imamura R; Amato VS
    PLoS One; 2019; 14(6):e0218786. PubMed ID: 31242231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.
    Guery R; Henry B; Martin-Blondel G; Rouzaud C; Cordoliani F; Harms G; Gangneux JP; Foulet F; Bourrat E; Baccard M; Morizot G; Consigny PH; Berry A; Blum J; Lortholary O; Buffet P;
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006094. PubMed ID: 29155816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective Study.
    Cunha MA; Leão AC; de Cassia Soler R; Lindoso JA
    Am J Trop Med Hyg; 2015 Dec; 93(6):1214-8. PubMed ID: 26483120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.
    Sundar S; Mehta H; Suresh AV; Singh SP; Rai M; Murray HW
    Clin Infect Dis; 2004 Feb; 38(3):377-83. PubMed ID: 14727208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: A Single-Center Case Series on Skin Manifestations of Leishmaniasis from a Non-Endemic State in Southern India.
    Tharakan SJ; Peter Cv D; Karthik R; Rupa V; Rose W; Thomas M; Manuel M; Rupali P; Pulimood S; Rao Ajjampur SS
    Am J Trop Med Hyg; 2020 Dec; 104(3):928-933. PubMed ID: 33377447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
    Brogden RN; Goa KL; Coukell AJ
    Drugs; 1998 Sep; 56(3):365-83. PubMed ID: 9777313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients.
    Rocio C; Amato VS; Camargo RA; Tuon FF; Nicodemo AC
    Trans R Soc Trop Med Hyg; 2014 Mar; 108(3):176-8. PubMed ID: 24535153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil.
    Borges MM; Pranchevicius MC; Noronha EF; Romero GA; Carranza-Tamayo CO
    Rev Soc Bras Med Trop; 2017; 50(1):67-74. PubMed ID: 28327804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients.
    Amato VS; Rabello A; Rotondo-Silva A; Kono A; Maldonado TP; Alves IC; Floeter-Winter LM; Neto VA; Shikanai-Yasuda MA
    Acta Trop; 2004 Oct; 92(2):127-32. PubMed ID: 15350864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the current and future status of conventional amphotericin B?
    Kleinberg M
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphotericin B Deoxycholate Treatment of Post-Kala-Azar Dermal Leishmaniasis in India.
    Sundar S; Chakravarty J; Singh J; Verma D; Agrawal N; Dinkar A
    Am J Trop Med Hyg; 2024 Jul; 111(1):59-63. PubMed ID: 38834057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal leishmaniasis . Current scenario and prospects for treatment.
    Amato VS; Tuon FF; Bacha HA; Neto VA; Nicodemo AC
    Acta Trop; 2008 Jan; 105(1):1-9. PubMed ID: 17884002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review.
    Mosimann V; Neumayr A; Paris DH; Blum J
    Acta Trop; 2018 Jun; 182():246-250. PubMed ID: 29550282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphotericin B colloidal dispersion.
    Patel R
    Expert Opin Pharmacother; 2000 Mar; 1(3):475-88. PubMed ID: 11249532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New World and Old World Leishmania Infections: A Practical Review.
    Kevric I; Cappel MA; Keeling JH
    Dermatol Clin; 2015 Jul; 33(3):579-93. PubMed ID: 26143433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system toxicity associated with liposomal amphotericin B therapy for cutaneous leishmaniasis.
    Glasser JS; Murray CK
    Am J Trop Med Hyg; 2011 Apr; 84(4):566-8. PubMed ID: 21460011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential treatment of deep fungal infections with amphotericin B deoxycholate and amphotericin B colloidal dispersion.
    Beović B; Lejko-Zupanc T; Pretnar J
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):507-11. PubMed ID: 9272385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of visceral leishmaniasis with amphotericin B colloidal dispersion.
    Berman J; Dietze R
    Chemotherapy; 1999 Jun; 45 Suppl 1():54-66. PubMed ID: 10394022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.
    Monge-Maillo B; López-Vélez R
    Drugs; 2013 Nov; 73(17):1889-920. PubMed ID: 24170665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.